Access & reimbursement

Precision cardiology is becoming the new oncology. Policy and reimbursement must catch up

CAR-T Starts Moving From Factory Medicine to In-Patient Engineering

Screwworm Turns Pet Treatment Into a One Health Preparedness Issue

ALS Survival Data Return to the Evidence Debate

Diarrhoeal Disease Progress Is Real. The Inequality Is Still Brutal.

Sanofi’s Tzield moves type 1 diabetes into disease modification, but access may decide who benefits

WHO is preparing to ration the obesity drug revolution before it becomes another access disaster

FSHD Gets a Stronger Biological Signal

ALS Immunotherapy Moves Into the Extension Phase
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
